ESMO Consensus Conference on malignant lymphoma: management of ‘ultra-high-risk’ patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ESMO Consensus Conference on malignant lymphoma: management of ‘ultra-high-risk’ patients

Published:2018-08 Issue:8 Volume:29 Page:1687-1700
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Hutchings M.,Ladetto M.,Buske C.,de Nully Brown P.,Ferreri A.J.M.,Pfreundschuh M.,Schmitz N.,Balari A. Sureda,van Imhoff G.,Walewski J.

Funder

European Society for Medical Oncology central funds

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/29/8/1687/25505169/mdy167.pdf

Reference108 articles.

1. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Tilly;Ann Oncol,2015

2. Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients;Dykewicz;Clin Infect Dis,2001

3. Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;d'Amore;Ann Oncol,2015

4. Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Eichenauer;Ann Oncol,2018

5. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Willemze;Ann Oncol,2018

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials—a LYSA and GLA/ DSHNHL collaboration;Leukemia;2024-08-16

2. Do Double-Expressor High-Grade B-Cell Lymphomas Really Need Intensified Treatment? A Report from the Real-Life Series of High-Grade B-Cell Lymphomas Treated with Different Therapeutic Protocols at the Institute of Oncology Ljubljana;Biomedicines;2024-01-25

3. Recent updates on central nervous system prophylaxis in patients with high-risk diffuse large B-cell lymphoma;Experimental Hematology & Oncology;2024-01-03

4. High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma;Journal of Clinical Oncology;2023-12-10

5. Central nervous system lymphomas—Assessment and treatment and prevention of central nervous system relapse;Hematological Oncology;2023-06-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3